Abstract:N6-methyladenosine (m6A) RNA methylation is identified as the most common, abundant and reversible RNA epigenetic modification in messenger RNA (mRNA) and non-coding RNA, especially within eukaryotic messenger RNAs (mRNAs), which post-transcriptionally directs many important processes of RNA. It has also been demonstrated that m6A modification plays a pivotal role in the occurrence and development of tumors by regulating RNA splicing, localization, translation, stabilization and decay. Growing number of studies have indicated that natural products have outstanding anti-cancer effects of their unique advantages of high efficiency and minimal side effects. However, at present, there are very few research articles to study and explore the relationship between natural products and m6A RNA modification in tumorigenesis. m6A is dynamically deposited, removed, and recognized by m6A methyltransferases (METTL3/14, METTL16, WTAP, RBM15/15B, VIRMA, CBLL1, and ZC3H13, called as “writers”), demethylases (FTO and ALKBH5, called as “erasers”), and m6A-specific binding proteins (YTHDF1/2/3, YTHDC1/2, IGH2BP1/2/3, hnRNPs, eIF3, and FMR1, called as “readers”), respectively. In this review, we summarize the biological function of m6A modification, the role of m6A and the related signaling pathway in cancer, such as AKT, NF-kB, MAPK, ERK, Wnt/β-catenin, STAT, p53, Notch signaling pathway, and so on. Furthermore, we reviewed the current research on nature products in anti-tumor, and further to get a better understanding of the anti-tumor mechanism, thus provide an implication for nature products with anti-cancer research by regulating m6A modification in the future.

Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer

The Regulation of N6‐methyladenosine Modification in PD‐L1‐induced Anti‐tumor Immunity

The emerging roles of N6-methyladenosine RNA methylation in human cancers

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

N6-methyladenosine modification: a novel pharmacological target for anti-cancer drug development

The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research

Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer

The Roles of M6a RNA Modifiers in Human Cancer

Regulatory effect of N6-methyladenosine on tumor angiogenesis

m6A modification: recent advances, anticancer targeted drug discovery and beyond

Small molecule inhibitors targeting m6A regulators

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

Small Molecules that Regulate the N 6 -Methyladenosine RNA Modification as Potential Anti-Cancer Agents

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer

N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications

The Roles of N6-methyladenosine and Its Target Regulatory Noncoding RNAs in Tumors: Classification, Mechanisms, and Potential Therapeutic Implications.

Potential applications of N6 -methyladenosine modification in the prognosis and treatment of cancers via modulating apoptosis, autophagy, and ferroptosis